Inflammatory Networks in Renal Cell Carcinoma

16Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Cancer-associated inflammation has been established as a hallmark feature of almost all solid cancers. Tumor-extrinsic and intrinsic signaling pathways regulate the process of cancer-associated inflammation. Tumor-extrinsic inflammation is triggered by many factors, including infection, obesity, autoimmune disorders, and exposure to toxic and radioactive substances. Intrinsic inflammation can be induced by genomic mutation, genome instability and epigenetic remodeling in cancer cells that promote immunosuppressive traits, inducing the recruitment and activation of inflammatory immune cells. In RCC, many cancer cell-intrinsic alterations are assembled, upregulating inflammatory pathways, which enhance chemokine release and neoantigen expression. Furthermore, immune cells activate the endothelium and induce metabolic shifts, thereby amplifying both the paracrine and autocrine inflammatory loops to promote RCC tumor growth and progression. Together with tumor-extrinsic inflammatory factors, tumor-intrinsic signaling pathways trigger a Janus-faced tumor microenvironment, thereby simultaneously promoting or inhibiting tumor growth. For therapeutic success, it is important to understand the pathomechanisms of cancer-associated inflammation, which promote cancer progression. In this review, we describe the molecular mechanisms of cancer-associated inflammation that influence cancer and immune cell functions, thereby increasing tumor malignancy and anti-cancer resistance. We also discuss the potential of anti-inflammatory treatments, which may provide clinical benefits in RCCs and possible avenues for therapy and future research.

References Powered by Scopus

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

5352Citations
N/AReaders
Get full text

Sorafenib in advanced clear-cell renal-cell carcinoma

4552Citations
N/AReaders
Get full text

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

4440Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Immunotherapy of Clear-Cell Renal-Cell Carcinoma

4Citations
N/AReaders
Get full text

Renal cancer: signaling pathways and advances in targeted therapies

2Citations
N/AReaders
Get full text

Impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombus

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kruk, L., Mamtimin, M., Braun, A., Anders, H. J., Andrassy, J., Gudermann, T., & Mammadova-Bach, E. (2023, April 1). Inflammatory Networks in Renal Cell Carcinoma. Cancers. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cancers15082212

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

57%

Researcher 2

29%

Professor / Associate Prof. 1

14%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

57%

Pharmacology, Toxicology and Pharmaceut... 1

14%

Agricultural and Biological Sciences 1

14%

Biochemistry, Genetics and Molecular Bi... 1

14%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free